Baird Medical Senior Advisor & CMO David Kaysen and Excelfin's COO Brian Sun

SPAC targets in the healthcare space typically are a few years
away from full commercialization, but shareholders
in Exelfin Acquisition Corp. (NASDAQ:XFIN) will get to
vote this week on a combination with a medical device company
that is already churning out positive EBITDA.


This week, we speak with Brian Sun, Chief Operating Officer of
Excelfin and David Kaysen, Senior Advisor and Chief Marketing
Officer for Baird Medical.


The two announced a $279 million dollar combination in June
2023. Brian explains why Excelfin diverted its initial focus
from fintech to medical devices.


David lays out how Baird has gotten this far through
commercialization in China and why it expects successful adoption
in the US. With the prospect of tariffs potentially
increasing between those two jurisdictions, they also explain how
Baird and Excelfin have a plan for that as well.